PROTEOMICS RESOURCE LABORATORY SHARED RESOURCE (PRL) The Proteomics Resource Laboratory (PRL) provides support for mass spectrometry-based proteomics analysis for all Perlmutter Cancer Center (PCC) investigators through a centralized facility, with state-of-the-art instrumentation and highly specialized technical expertise. Under the direction of Dr. Beatrix Ueberheide, a well-established expert in biological mass spectromety, PRL was established 5 years ago to expand upon the successful Proteomics Core. PRL aids scientific discovery at PCC by providing access to specialized expertise and state-of-the-art instrumentation for the analysis of proteins and peptides using mass spectrometry (MS). A special focus of the laboratory is assistance with experimental design and full support for downstream data analysis, often involving innovative data analysis pipelines. Significant economies of scale are achieved by this centralization of resources. PRL achieves its mission via four Specific Aims:
Aim 1) To provide mass spectrometry-based, state-of-the-art proteomics technologies to PCC investigators and full downstream data analysis support;
Aim 2) To provide highly customized support tailored to specific projects and research questions of PCC investigators;
Aim 3) To develop and implement novel techniques to ensure continued support of state-of-the-art proteomics technology for PCC investigators;
Aim 4) To provide education to graduate students and post-doctoral researchers on proteomics techniques through graduate teaching and close collaboration with PCC investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-40
Application #
10124319
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-12-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
40
Fiscal Year
2021
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9

Showing the most recent 10 out of 1170 publications